Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur

Ultrasound Guided Fascia Iliaca Block Versus Intravenous Dexmedetomidine and Ketamine for Positioning Fracture Femur Patients During Spinal Anesthesia: Randomized Comparison Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT05705726

Enrollment

Registered

2023-01-31

Start date

2023-02-11

Completion date

2024-07-01

Last updated

2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain, Analgesia

Brief summary

Proximal femur fractures are one of the commonest fractures especially in the elderly population. Early surgical fixation is the best analgesic for associated pain. Spinal anesthesia has been favored by many anesthesiologists due to the simplicity of the technique, the better analgesic profile, and the lower incidence of complications like delirium and thromboembolic events. However, severe pain, encountered during positioning for spinal anesthesia, can complicate the technique and worsen the patient experience. the study aim to compare the analgesic effect of intravenous dexmedetomidine and fascia iliaca block preoperatively to assist positioning patients for performance of spinal anesthesia.

Interventions

DEVICEultrasound guided facia iliaca block

Patient will received ultrasound guided fascia iliaca block by 20 ml Bupivacaine 0,25% .

DRUGIntravenous drug

Patient will received intravenous injection of precedex 0.25mic/Kg and ketamine 0,2 mg/kg .

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

1. Aged 18-60 years. 2. Hip fractures 3. Both sexes.

Exclusion criteria

1. Patient refusal 2. Allergy to local anesthetics 3. Bleeding diathesis or history of anticoagulant use. 4. impaired cognition or dementia 5. . Infection of the skin at the site of needle punctures area 6. multiple fractures 7. Any previous analgesic administration during the last 12 hours

Design outcomes

Primary

Measure	Time frame	Description
Behavioral pain scale	during spinal anesthesia	0 = calm, 1 = facial grimacing, 2 = moaning, 3 = screaming, and 4 = unable to proceed because of restlessness or agitation

Secondary

Measure	Time frame	Description
Quality of patient's position	before spinal anesthesia	0 = poor hip flexion, 1 = satisfactory hip flexion, 2 = good hip flexion, and 3 = optimal hip flexion

Countries

Egypt

Contacts

Primary Contacthassan m. hetta, lecturer

hassan.hetta@mu.edu.eg1010901114

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026